BACKGROUND: @entity1653 accounts for about 4.7% to 7.2% of all kinds of @entity1653 , which is invasive with a relatively high recurrence and mortality. The objective of this study was to investigate the clinical manifestations and therapeutic strategies of @entity1653 . METHODS: A total of 74 @entity1 who underwent surgical treatment and pathologically confirmed for @entity1653 in Neurosurgery Department of Beijing Tiantan Hospital from January 2003 to December 2008 were enrolled in this study. The characteristics of the @entity5 as well as therapeutic regimens and follow-up data were reviewed. After surgery, 56 @entity1 underwent radiotherapy. @entity1 were followed up for about 3.5 years (range, 0.5 - 6.0 years), and 58 @entity1 completed follow-up. RESULTS: Of the 58 @entity1 who completed follow-up, good recovery was found in 30, @entity51 in 15, and @entity204 in 13. Of the 58 @entity1 , 21 had recurrent @entity1653 and 18 underwent a second surgery. CONCLUSIONS: @entity1653 is difficult to manage, with a high recurrence rate and poor survival. The extent of @entity5 resection and histological grade are the key determinants of outcome. Radiation therapy can be used as an adjunctive treatment after total or partial resection.

Clinical characteristics and therapeutic strategies of XXXX .

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'tumors'] @entity51 :: ('MESH:D009461', 'Disease') :: ['neurological dysfunction'] @entity1653 :: ('MESH:D008579', 'Disease') :: ['meningioma', 'Atypical meningioma', 'atypical meningioma', 'meningiomas'] @entity204 :: ('MESH:D003643', 'Disease') :: ['death']
@entity1653 :: (MESH:D008579,Disease) :: ['atypical meningioma']
